Of note, we recently found that APP Tyr682 phosphorylation increases in fibroblasts of AD patients [16], opening up to the possibility to use APP Tyr682 phosphorylation level as a potential powerful tool in detecting early signs of AD-related cognitive disorders in peripheral cells. Here, APP is linked to cognitive disorder.